Assignee
ANADYS PHARMACEUTICALS INC
US·39 granted patents·16 pending applications·534 citations·filing 1997–2014
Top patents by PatentIndex Score
55 records- 0197US8034802B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2009·Granted Oct 11, 2011·43 cites·33 claims
- 0297US7576068B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2004·Granted Aug 18, 2009·91 cites·20 claims
- 0397US6924271B23-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2002·Granted Aug 2, 2005·123 cites·10 claims
- 0492US7560544B23,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofANADYS PHARMACEUTICALS INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0591US7834009B24-hydroxy-5,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Nov 16, 2010·11 cites·19 claims
- 0690US7939524B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2008·Granted May 10, 2011·16 cites·27 claims
- 0789US7709448B2Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dioneANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·13 cites·8 claims
- 0888US6569628B2Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·16 cites·9 claims
- 0987US7582626B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Sep 1, 2009·13 cites·20 claims
- 1085US7745415B23-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2008·Granted Jun 29, 2010·6 cites·12 claims
- 1185US7582754B2Pyrro[1,2-b]pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2008·Granted Sep 1, 2009·6 cites·4 claims
- 1283US7462611B2Pyrro[1,2-b]pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Dec 9, 2008·5 cites·23 claims
- 1383US7425552B2Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2005·Granted Sep 16, 2008·7 cites·14 claims
- 1483US7223759B2Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compoundsANADYS PHARMACEUTICALS INC·Filed 2004·Granted May 29, 2007·21 cites·11 claims
- 1580US7928085B2P-toluene sulfonic acid salt of 5-amino-3-(2′-O-acetyl-3′-deoxy-β-D-ribofuranosyl)-3H-thiazole[4,5-d]pyrimidine-2-one and methods for preparationANADYS PHARMACEUTICALS INC·Filed 2007·Granted Apr 19, 2011·4 cites·10 claims
- 1680US6331392B1Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·29 cites·9 claims
- 1779US7943759B23-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2010·Granted May 17, 2011·3 cites·6 claims
- 1879US6503721B2Screen for compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted Jan 7, 2003·12 cites·9 claims
- 1977US6531289B1Regulated gene expression in yeast and method of useANADYS PHARMACEUTICALS INC·Filed 2000·Granted Mar 11, 2003·6 cites·10 claims
- 2077US6329378B1Hydrazone, hydrazine and thiosemicarbazone derivatives as antifungal agentsANADYS PHARMACEUTICALS INC·Filed 2000·Granted Dec 11, 2001·13 cites·11 claims
- 2176US7321033B23-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·7 cites·11 claims
- 2275US7528115B2Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidinesANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 5, 2009·2 cites·15 claims
- 2371US9227992B2Method of preparing deoxyribofuranose compoundsANADYS PHARMACEUTICALS INC·Filed 2014·Granted Jan 5, 2016·0 cites·1 claims
- 2469US2011229438A1Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compoundsANADYS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2568US7842838B2Pyrro[1,2-b]pyridazinone intermediatesANADYS PHARMACEUTICALS INC·Filed 2009·Granted Nov 30, 2010·0 cites·4 claims
- 2668US6930095B2Hepatitis C virus constructs characterized by high efficiency replicationANADYS PHARMACEUTICALS INC·Filed 2001·Granted Aug 16, 2005·12 cites·8 claims
- 2768US6228882B1Pyronin antibacterials, process and novel intermediates theretoANADYS PHARMACEUTICALS INC·Filed 1999·Granted May 8, 2001·8 cites·10 claims
- 2867US6451582B1Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factorANADYS PHARMACEUTICALS INC·Filed 2000·Granted Sep 17, 2002·2 cites·14 claims
- 2965US9156832B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2014·Granted Oct 13, 2015·0 cites·18 claims
- 3064US8765741B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·0 cites·22 claims
- 3161US2005182001A13-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3259US2014066396A1Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compoundsANADYS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3358US6191288B1Pyronin antibacterials, process and novel intermediates theretoANADYS PHARMACEUTICALS INC·Filed 1999·Granted Feb 20, 2001·14 cites·13 claims
- 3458US2008090844A13-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3557US2007197533A1Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3655US2013137143A1Semi-continuous and continuous enzymatic hydrolysis processANADYS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3755US2011166092A1Dosing methods for treating diseaseANADYS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3854US9161946B2Dosing methods for treating diseaseANADYS PHARMACEUTICALS INC·Filed 2013·Granted Oct 20, 2015·0 cites·4 claims
- 3952US6355469B1Nucleic acid encoding M. tuberculosis algu proteinANADYS PHARMACEUTICALS INC·Filed 1998·Granted Mar 12, 2002·9 cites·4 claims
- 4051US2008292588A11-methyl-benzo[1,2,4]thiadiazine 1-oxide derivativesANADYS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4148US2008188466A1Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4247US7781581B2Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-oneANADYS PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·0 cites·16 claims
- 4347US6358708B1Candida albicans SRB-7ANADYS PHARMACEUTICALS INC·Filed 2000·Granted Mar 19, 2002·0 cites·6 claims
- 4447US2010286081A15-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] pyrimidin-2-oce salts and crystalline formsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4546US2008090814A1Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4644US6610508B1Translation driver system and methods for use thereofANADYS PHARMACEUTICALS INC·Filed 1999·Granted Aug 26, 2003·15 cites·107 claims
- 4744US2005075375A1Heterocyclic compounds for treating hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 4843US2002055123A1Screening method for identifying ligands for target proteinsANADYS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4941US2005260221A1Hepatitis C virus constructs characterized by high efficiency replicationANADYS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 5037US2003027243A1Antifungal compounds and methods of useANADYS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ANADYS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →